However, our findings showed that USP4 or S1P1 overexpression was insufficient to facilitate EMT, implying that a set of dysregulated miRNAs (e.g., miR-125b and miR-101) may contribute to phenotype changes, depending on the stage and progression of HCC [28,29]. The gene discussed is USP4; the disease is hepatocellular carcinoma.